DE69421617T2 - Homogene immunoassays unter verwendung von mutanten glucose-6-phosphatdehydrogenasen - Google Patents

Homogene immunoassays unter verwendung von mutanten glucose-6-phosphatdehydrogenasen

Info

Publication number
DE69421617T2
DE69421617T2 DE69421617T DE69421617T DE69421617T2 DE 69421617 T2 DE69421617 T2 DE 69421617T2 DE 69421617 T DE69421617 T DE 69421617T DE 69421617 T DE69421617 T DE 69421617T DE 69421617 T2 DE69421617 T2 DE 69421617T2
Authority
DE
Germany
Prior art keywords
g6pdh
enzymes
precursor
subject
substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69421617T
Other languages
English (en)
Other versions
DE69421617D1 (de
Inventor
Edward Jakobovits
Joy Silen
Mark Levy
Thomas Goodman
Martin Becker
Edwin Ullman
Robert Caldwell
Richard Bott
Christopher Barnett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Products GmbH
Danisco US Inc
Original Assignee
Behringwerke AG
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG, Genencor International Inc filed Critical Behringwerke AG
Publication of DE69421617D1 publication Critical patent/DE69421617D1/de
Application granted granted Critical
Publication of DE69421617T2 publication Critical patent/DE69421617T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/904Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69421617T 1993-04-08 1994-04-07 Homogene immunoassays unter verwendung von mutanten glucose-6-phosphatdehydrogenasen Expired - Lifetime DE69421617T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/044,857 US6455288B1 (en) 1993-04-08 1993-04-08 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
PCT/US1994/003437 WO1994024559A2 (en) 1993-04-08 1994-04-07 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases

Publications (2)

Publication Number Publication Date
DE69421617D1 DE69421617D1 (de) 1999-12-16
DE69421617T2 true DE69421617T2 (de) 2000-03-02

Family

ID=21934701

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69421617T Expired - Lifetime DE69421617T2 (de) 1993-04-08 1994-04-07 Homogene immunoassays unter verwendung von mutanten glucose-6-phosphatdehydrogenasen

Country Status (8)

Country Link
US (3) US6455288B1 (de)
EP (1) EP0710360B1 (de)
JP (1) JP4223546B2 (de)
AT (1) ATE186598T1 (de)
CA (1) CA2160115A1 (de)
DE (1) DE69421617T2 (de)
ES (1) ES2139087T3 (de)
WO (1) WO1994024559A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741715A (en) * 1995-05-30 1998-04-21 Roche Diagnostic Systems, Inc. Quinidine immunoassay and reagents
CA2290582C (en) 1997-05-14 2005-08-02 Kenneth F. Buechler Rapid evaluation of the ratio of biological molecules
US6306616B1 (en) 1998-03-27 2001-10-23 Microgenics Corporation Adsorption type confirmatory assays
JP2002065283A (ja) * 2000-06-12 2002-03-05 Wako Pure Chem Ind Ltd ハイブリッド酵素およびその用途
US7560239B2 (en) * 2002-06-04 2009-07-14 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for simultaneous detection of multiple analytes
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7115383B2 (en) * 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
US7037669B2 (en) * 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US7279340B2 (en) * 2004-04-07 2007-10-09 Dade Behring Inc. Synthesis and application of procainamide analogs for use in an immunoassay
US20060046273A1 (en) * 2004-08-27 2006-03-02 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for oral fluid
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
US8507280B2 (en) * 2006-08-18 2013-08-13 Ortho-Clinical Diagnostics, Inc. Method of normalizing surface tension of a sample fluid
US8828665B2 (en) 2007-02-16 2014-09-09 Ark Diagnostics, Inc. Compounds and methods for use in detecting gabapentin
US7790401B2 (en) 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
US7910378B2 (en) 2007-12-14 2011-03-22 Siemens Healthcare Diagnostics Inc. Methods for detection of hydrophobic drugs
US20090226900A1 (en) * 2008-03-05 2009-09-10 Helicos Biosciences Corporation Methods for Reducing Contaminants in Nucleic Acid Sequencing by Synthesis
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
WO2010048423A1 (en) 2008-10-24 2010-04-29 Ark Diagnostics, Inc. Levetiracetam immunoassays
ES2569238T3 (es) * 2009-07-10 2016-05-09 Linzy O. Scott Iii Procedimientos y composiciones para tratar afecciones médicas relacionadas con la tiroides con folatos reducidos
US8329424B2 (en) 2010-06-25 2012-12-11 Siemens Healthcare Diagnostics Reduction in false results in assay measurements
US8771964B2 (en) 2012-02-02 2014-07-08 Siemens Healthcare Diagnostics Inc. Compositions and methods for detection of methadone metabolite
US9658218B2 (en) 2012-05-07 2017-05-23 Siemens Healthcare Diagnostics Inc. Determination of total analyte concentration
US9121859B2 (en) 2012-12-04 2015-09-01 Siemens Healthcare Diagnostics Inc. Compounds and methods for determination of FKBP-binding immunosuppressant drugs
WO2014113717A1 (en) 2013-01-18 2014-07-24 Ark Diagnostics, Inc. Voriconazole immunoassays
EP2956444B1 (de) 2013-02-13 2018-05-30 ARK Diagnostics, Inc. Posaconazol-immunoassays
EP3041576B1 (de) 2013-09-05 2019-06-19 IDEXX Laboratories, Inc. Verfahren für den nachweis von nierenerkrankungen
WO2015067302A1 (en) 2013-11-05 2015-05-14 Ecole Polytechnique Federale De Lausanne (Epfl) Sensor molecules and uses thereof
EP3083657B1 (de) 2013-12-17 2022-01-26 Siemens Healthcare Diagnostics Inc. Herstellung von mutanten g6pdh-konjugaten it mehreren haptenen und deren verwendung zur detektion mehrerer analyte
US10351830B2 (en) 2014-12-17 2019-07-16 Siemens Healthcare Diagnostics Inc. Conjugates for assays for oxycodone and oxymorphone
CN107250795B (zh) 2015-02-20 2021-07-30 艾德克斯实验室公司 带有对背景信号的补偿的均相免疫测定
EP3265074B1 (de) 2015-03-03 2020-08-12 ARK Diagnostics, Inc. Pregabalinimmunoassays
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11422136B2 (en) 2017-10-19 2022-08-23 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
CN110174363A (zh) * 2019-01-09 2019-08-27 北京九强生物技术股份有限公司 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途
US10745492B1 (en) 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
CN111999500B (zh) * 2019-04-19 2023-04-18 北京九强生物技术股份有限公司 卡马西平检测试剂盒
CN110054620B (zh) * 2019-04-19 2021-01-26 北京九强生物技术股份有限公司 一种苯巴比妥衍生物及其在免疫检测中的用途
CN115684613A (zh) * 2019-07-04 2023-02-03 北京九强生物技术股份有限公司 丙戊酸检测试剂盒
US20210048436A1 (en) 2019-08-15 2021-02-18 Psychemedics Corporation Homogeneous enzyme immunoassay for keratinized structures
CN113614514B (zh) * 2020-01-07 2022-11-25 北京九强生物技术股份有限公司 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4233401A (en) 1977-07-14 1980-11-11 Syva Company Antienzyme homogeneous competitive binding assay
IT1199088B (it) * 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
US4622294A (en) * 1985-02-08 1986-11-11 Kung Viola T Liposome immunoassay reagent and method
DE3711881A1 (de) * 1987-04-08 1988-10-27 Merck Patent Gmbh Verfahren zur herstellung von glucosedehydrogenase aus bacillus megaterium
JPH0286779A (ja) * 1988-09-22 1990-03-27 Amano Pharmaceut Co Ltd 改良型組換えdna、それを含む形質転換体及びそれを用いた耐熱性グルコースデヒドロゲナーゼの製造法
DE4024158A1 (de) 1990-07-30 1992-02-06 Boehringer Mannheim Gmbh Klonierung und ueberexpression von glucose-6-phosphat-dehydrogenase aus leuconostoc dextranicus
JP2850515B2 (ja) * 1990-09-25 1999-01-27 東洋紡績株式会社 グルコースデヒドロゲナーゼおよびその製造法
US5244796A (en) * 1990-10-12 1993-09-14 Syracuse University Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making glucose-6-phospate dehydrogenase
DK0487301T3 (da) 1990-11-20 2000-09-18 Dade Behring Marburg Gmbh Fremgangsmåde til stabilisering af enzymkonjugater

Also Published As

Publication number Publication date
US6033890A (en) 2000-03-07
DE69421617D1 (de) 1999-12-16
US6090567A (en) 2000-07-18
ES2139087T3 (es) 2000-02-01
JPH08510638A (ja) 1996-11-12
EP0710360A1 (de) 1996-05-08
ATE186598T1 (de) 1999-11-15
JP4223546B2 (ja) 2009-02-12
CA2160115A1 (en) 1994-10-27
WO1994024559A2 (en) 1994-10-27
US6455288B1 (en) 2002-09-24
WO1994024559A3 (en) 1995-01-26
EP0710360B1 (de) 1999-11-10

Similar Documents

Publication Publication Date Title
DE69421617D1 (de) Homogene immunoassays unter verwendung von mutanten glucose-6-phosphatdehydrogenasen
Kessler et al. Ultrastructure and pyruvate formate-lyase radical quenching property of the multienzymic AdhE protein of Escherichia coli.
Gitlitz et al. Structural and catalytic properties of hydrogenase from Chromatium
WO1996039429A3 (en) Serum protein produced exclusively in adipocytes
KR910015700A (ko) 지시약중에 사용하기 위한 개선된 비활성을 갖는 알칼린 포스타파제 효소
KIZER et al. Purification and characterization of a peptidyl glycine monooxygenase from porcine pituitary
MX9406538A (es) Inmunoensayo de complementacion enzimatica electroquimica.
DK1144447T3 (da) Dianostisk tuberkulosetest
BR0209425A (pt) Molécula de ácido nucleico isolada, célula hospedeira, polipeptìdeo isolado, anticorpo, métodos para produzir um polipeptìdeo e para detectar a presença de um polipeptìdeo e de uma molécula de ácido nucleico, kit, métodos para produzir acetaldeìdo e etanol, extrato de enzima, método para selecionar uma enzima de piruvato descarbixilase, e, plasmìdeo
CA2272273A1 (en) Methods, apparatus and computer program products for determining quantities of nucleic acid sequences in samples using standard curves and amplification ratio estimates
Ko et al. The amino acid sequence of the C‐peptide of human proinsulin
MX9606463A (es) Secuencias de nucleotido de las cepas pestivirus, polipeptidos codificados por estas secuencias y usos de los mismos para la diagnosis y prevencion de infecciones con pestivirus.
ATE511538T1 (de) Thermostabile mutanten pyrrolochinolin-chinon- abhängiger glucose-dehydrogenase
AUPO128096A0 (en) Biosensors
CA2570593A1 (en) Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion
AU1785099A (en) Novel gene having reverse transcriptase motif
ZA967411B (en) Blue copper oxidase mutants with enhanced activity
EP0922958A3 (de) Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
Isas et al. Purification and characterization of a NADP+/NADPH-specific flavoprotein that is overexpressed in FdI-strains of Azotobacter vinelandii.
AU2003260392A1 (en) Method for enriching a prokaryotic dna
Groβ et al. Screening method for microorganisms producing L-aminoacids from D, L-5-monosubstituted hydantoins
Toyama et al. PqqC/D, which converts a biosynthetic intermediate to pyrroloquinoline quinone
Ishihara et al. The presence of 4′-phosphopantetheine in the bacitracin synthetase
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
Grant et al. D-3-Phosphoglycerate dehydrogenase from chicken liver. II. Chemical and physical properties.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DADE BEHRING MARBURG GMBH, 35041 MARBURG, DE GENEN

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GENENCOR INTERNATIONAL, INC., SOUTH SAN FRANCI, US

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, , DE